Pine Pharmaceuticals has recalled 932 syringes of Bevacizumab (2.5 mg/0.1 mL) solution for injection because the individual syringes may be labeled with the wrong lot number. This medication is a repackaged injectable drug intended for clinical use in hospitals and medical offices. The recall was initiated because the primary syringe packaging may display lot number 66316 instead of the correct lot number 66377. No injuries or adverse events have been reported in connection with this labeling error.
The incorrect lot number on the packaging makes it difficult to accurately track and manage the medication if there were a separate quality issue. While the labeling error itself is a low risk to health, correct identification is essential for patient safety and inventory management.
Primary packaging (poly envelopes) may be labeled incorrectly as lot # 66316 while secondary packaging (cardboard box) indicates lot # 66377. Repackaged for Office Use Only.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.